Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Histoplasmosis
ADR ID BADD_A02081
ADR Hierarchy
11      Infections and infestations
11.03      Fungal infectious disorders
11.03.06      Histoplasma infections
11.03.06.001      Histoplasmosis
Description Infection resulting from exposure to the fungus HISTOPLASMA. It is worldwide in distribution and particularly common in the central and eastern states, especially areas around the Ohio and Mississippi River valleys. [MeSH]
MedDRA Code 10020141
MeSH ID D006660
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acute histoplasmosis | Chronic histoplasmosis | Histoplasmosis | Histoplasmosis acute | Histoplasmosis chronic | Histoplasmosis NOS | Histoplasmosis, unspecified | Histoplasmosis, unspecified with mention of other manifestation | Histoplasmosis, unspecified without mention of manifestation | Infection by Histoplasma capsulatum | Infection by histoplasma capsulatum, with mention of other manifestation | Infection by histoplasma capsulatum, without mention of manifestation | Infection by Histoplasma duboisii | Infection by histoplasma duboisii with mention of other manifestation | Infection by histoplasma duboisii, without mention of manifestation | Infection histoplasmosis | Histoplasmoses | Histoplasma Infection | Histoplasma Infections | Infection, Histoplasma | Infections, Histoplasma | Histoplasma capsulatum Infection | Histoplasma capsulatum Infections | Infection, Histoplasma capsulatum | Infections, Histoplasma capsulatum
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00041Adalimumab--
BADD_D00195Azathioprine0.002154%
BADD_D00416Certolizumab pegol--
BADD_D01217Itraconazole0.012107%
BADD_D01418Methotrexate--
BADD_D01419Methotrexate sodium--
BADD_D01717Pentamidine--
BADD_D01834Prednisone0.000338%
BADD_D02105Tacrolimus0.001481%
BADD_D02150Temozolomide0.000533%
BADD_D02236Tofacitinib0.001737%
BADD_D02464Fingolimod0.001737%
The 1th Page    1    Total 1 Pages